m+Medelevator.RU
← Поиск публикаций
bioRxiv : the preprint server for biology · 2026

A post-translational regulatory map of chronic antigen-driven human T cell dysfunction.

СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Kojima Hiroyuki, Wayne Charlotte R, Somarribas Patterson Luis F, Sanford Henry, Chen Tzu-Jou, Lin Ya-Hui, Schoenfeld Joshua D, McGary Lisa H F, Chen Yan-Ting, Kropp Korbinian N, Zhang Beatrice, Rahman Jahan, Zhang Tiffany L, Ropek Nathalie, Roberts Cameron, Ai Yuxi, Menon Kartikeya M, Hakimi A Ari, Lyu Jiankun, Klebanoff Christopher A, Abdel-Wahab Omar, Vardhana Santosha A, Vinogradova Ekaterina V

Аннотация

T cells exposed to persistent antigen in the context of chronic viral infections or cancer lose self-renewal and cytotoxic capacity. Several transcriptional, epigenetic, and metabolic drivers of this process have been identified. However, the post-transcriptional regulatory mechanisms influencing the proteome of dysfunctional T cells are not well understood. Here we present a time-resolved molecular landscape of human T cells during the development of chronic antigen-driven dysfunction. Persistent T cell receptor stimulation significantly remodeled the proteome, including changes in canonical T cell exhaustion-associated proteins and proteins related to mitochondrial function, redox homeostasis, nucleotide metabolism, and cell-cycle progression. Dysfunctional T cells displayed activation of stress response pathways that were recapitulated in vivo; targeting these pathways altered the cytotoxic capacity of T cells during persistent tumor exposure. Our comprehensive proteomic resource reveals unique post-transcriptional changes in dysfunctional T cells and lays the groundwork for novel cysteine-directed therapeutics to enhance cancer immunotherapy.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты